ALS Center of Excellence

Pranger ALS Clinic

  • Home
  • About
    • What Is ALS?
    • Scott L. Pranger
    • National Advisory Board
    • Faculty & Staff
    • ALS Center of Excellence Brochure
  • Clinic
    • Services
    • Your Visit to the ALS Clinic
    • Patient Portal
    • Durable Medical Equipment
    • Frequently Asked Questions
  • Research
    • Clinical Trials
    • Observational Studies
    • Participate in Research at U-M
  • News
  • Patient Care Guide
    • Living with ALS
    • Nutrition
    • Patient & Family Support
  • Contact
  • NeuroNetwork
  • Make A Gift

Latest News

ALS Risk Higher Among Production Workers

… [Read More...]

“Research Into Preventing ALS…”

… [Read More...]

portrait of Dr. Eva Feldman in her lab

Dr. Feldman Given Highest University of Michigan Honor

… [Read More...]

Multidisciplinary Team Publishes Paper on ALS Occupational Risk

… [Read More...]

The ANA Q&A: Dr. Eva Feldman on ALS

… [Read More...]

New Drug Combination May Slow Symptom Course Early on in ALS

September 4, 2020

Positive clinical trial points to a possible additional option for patients with ALS. Dr. Stephen Goutman explains the excitement and the caution.

from the M Health Lab Blog by Haley Otman

A new drug combination could help slow the effects of amyotrophic lateral sclerosis, or ALS, on patients’ day-to-day ability to function, such as eating independently, walking and speaking.

“ALS is a disease where the motor neuron cells die, and the hope with this drug is, if given early, it may slow the death of these motor neuron cells that lead to weakness and progression of ALS,” says Stephen Goutman, M.D., director of the Michigan Medicine Pranger ALS Clinic(link is external) and one of the researchers who led a trial site for the drug.

ALS, also known as Lou Gehrig’s disease, is fatal, so any new treatments offer hope for those living with the disease.

“This is an exciting study and I’m glad we could allow our patients at the Pranger ALS Clinic to participate,” Goutman says. “However, the need for a cure still exists and we remain committed to continuing this work.”

Read More

Share this:

  • Facebook
  • Twitter
  • LinkedIn

Filed Under: News, Press

Newsletter Signup

Subscribe to our mailing list for updates regarding our clinic and research

Click Here for the ALS Registry

ALS Center of Excellence at Michigan Medicine ALS Infographic

ALS Brochure

ALS Brochure

 

 

 

 

 

Resources

Organizations

  • ALS Association
  • ALSA-Michigan Chapter
  • Ann Arbor Active Against ALS
  • ALSA-Northern Ohio Chapter
  • ALS of Michigan
  • National ALS Registry
  • Northeast ALS Consortium
  • Muscular Dystrophy Association

Services

  • Veterans Benefits
  • Social Security Benefits

Useful Links

  • U-M Stem Cell Research
  • Center for Stem Cell Biology
  • Human Embryonic Stem Cell Research
  • Society for Stem Cell Research

RSS Research News

  • U-M to establish new Institute for Firearm Injury Prevention
  • U-M Depression Center to be named for Eisenberg family, in recognition of $30M in giving
  • Research on aging expands at U-M with $15M in new grants

Contact Information

Michigan Medicine
1500 E. Medical Center Drive
Ann Arbor, MI 48109
Phone: 734-936-4000
Contact Michigan Medicine

Connect With Us

Copyright © 2023 Regents of the University of Michigan · Disclaimer · Privacy Statement

  • About UMHS
  • For Patients
  • For Health Professionals
  • For Researchers
  • Home
  • About
    ▼
    • What Is ALS?
    • Scott L. Pranger
    • National Advisory Board
    • Faculty & Staff
    • ALS Center of Excellence Brochure
  • Clinic
    ▼
    • Services
    • Your Visit to the ALS Clinic
    • Patient Portal
    • Durable Medical Equipment
    • Frequently Asked Questions
  • Research
    ▼
    • Clinical Trials
    • Observational Studies
    • Participate in Research at U-M
  • News
  • Patient Care Guide
    ▼
    • Living with ALS
    • Nutrition
    • Patient & Family Support
  • Contact
  • NeuroNetwork
  • Make A Gift